Search research articles
Contact Us
Filters
Showing results (81-90 of 122) with videos related to
Page
of 13
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2013
PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs
Ken A Olaussen, Julien Adam, Elsa Vanhecke, et al.
Plos One
|
March 5, 2013
EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells
Anna Rommer, Birgit Steinmetz, Friederike Herbst, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2020
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
Peter C Dubsky, Christian F Singer, Daniel Egle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2013
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer, Monika Artl, Martin Filipits, et al.
The New England Journal of Medicine
|
September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Neuro-Oncology
|
October 31, 2014
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, et al.
Breast Cancer Research and Treatment
|
January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
International Journal of Cancer
|
October 11, 2014
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
Daniel Veigel, Renate Wagner, Gerald Stübiger, et al.
Breast (Edinburgh, Scotland)
|
February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 122) with videos related to
Sort By:
Page
of 13
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2013
PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs
Ken A Olaussen, Julien Adam, Elsa Vanhecke, et al.
Plos One
|
March 5, 2013
EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells
Anna Rommer, Birgit Steinmetz, Friederike Herbst, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2020
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
Peter C Dubsky, Christian F Singer, Daniel Egle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2013
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer, Monika Artl, Martin Filipits, et al.
The New England Journal of Medicine
|
September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Neuro-Oncology
|
October 31, 2014
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, et al.
Breast Cancer Research and Treatment
|
January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
International Journal of Cancer
|
October 11, 2014
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
Daniel Veigel, Renate Wagner, Gerald Stübiger, et al.
Breast (Edinburgh, Scotland)
|
February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Page
of 13